EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaSara Charmsaz, Andy Boyd|Leukemia|2016Cited by 38
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaSara Charmsaz, Andy Boyd|PLoS ONE|2015Cited by 23